Abstract:Motivated by the question, "Can we generate tumors with desired attributes?'' this study leverages radiomics features to explore the feasibility of generating synthetic tumor images. Characterized by its low-dimensional yet biologically meaningful markers, radiomics bridges the gap between complex medical imaging data and actionable clinical insights. We present RadiomicsFill-Mammo, the first of the RadiomicsFill series, an innovative technique that generates realistic mammogram mass images mirroring specific radiomics attributes using masked images and opposite breast images, leveraging a recent stable diffusion model. This approach also allows for the incorporation of essential clinical variables, such as BI-RADS and breast density, alongside radiomics features as conditions for mass generation. Results indicate that RadiomicsFill-Mammo effectively generates diverse and realistic tumor images based on various radiomics conditions. Results also demonstrate a significant improvement in mass detection capabilities, leveraging RadiomicsFill-Mammo as a strategy to generate simulated samples. Furthermore, RadiomicsFill-Mammo not only advances medical imaging research but also opens new avenues for enhancing treatment planning and tumor simulation. Our code is available at https://github.com/nainye/RadiomicsFill.
Abstract:We introduce RadiomicsFill, a synthetic tumor generator conditioned on radiomics features, enabling detailed control and individual manipulation of tumor subregions. This conditioning leverages conventional high-dimensional features of the tumor (i.e., radiomics features) and thus is biologically well-grounded. Our model combines generative adversarial networks, radiomics-feature conditioning, and multi-task learning. Through experiments with glioma patients, RadiomicsFill demonstrated its capability to generate diverse, realistic tumors and its fine-tuning ability for specific radiomics features like 'Pixel Surface' and 'Shape Sphericity'. The ability of RadiomicsFill to generate an unlimited number of realistic synthetic tumors offers notable prospects for both advancing medical imaging research and potential clinical applications.